Literature DB >> 18021174

Akt is transferred to the nucleus of cells treated with apoptin, and it participates in apoptin-induced cell death.

S Maddika1, G H Bay, T J Kroczak, S R Ande, S Maddika1, E Wiechec, S B Gibson, M Los.   

Abstract

OBJECTIVES: The phosphatidylinositol 3-kinase (PI3-K)/Akt pathway is well known for the regulation of cell survival, proliferation, and some metabolic routes.
MATERIALS AND METHODS: In this study, we document a novel role for the PI3-K/Akt pathway during cell death induced by apoptin, a tumour-selective inducer of apoptosis.
RESULTS: We show for the first time that apoptin interacts with the p85 regulatory subunit, leading to constitutive activation of PI3-K. The inhibition of PI3-K activation either by chemical inhibitors or by genetic approaches severely impairs cell death induced by apoptin. Downstream of PI3-K, Akt is activated and translocated to the nucleus together with apoptin. Direct interaction between apoptin and Akt is documented. Co-expression of nuclear Akt significantly potentiates cell death induced by apoptin. Thus, apoptin-facilitated nuclear Akt, in contrast to when in its cytoplasmic pool, appears to be a positive regulator, rather than repressor of apoptosis.
CONCLUSIONS: Our observations indicate that PI3-K/Akt pathways have a dual role in both survival and cell death processes depending on the stimulus. Nuclear Akt acts as apoptosis stimulator rather than as a repressor, as it likely gains access to a new set of substrates in the nucleus. The implicated link between survival and cell death pathways during apoptosis opens new pharmacological opportunities to modulate apoptosis in cancer, for example through the manipulation of Akt's cellular localization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021174      PMCID: PMC2954966          DOI: 10.1111/j.1365-2184.2007.00475.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  51 in total

Review 1.  Signaling by distinct classes of phosphoinositide 3-kinases.

Authors:  B Vanhaesebroeck; M D Waterfield
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

Review 2.  Caspases: more than just killers?

Authors:  M Los; C Stroh; R U Jänicke; I H Engels; K Schulze-Osthoff
Journal:  Trends Immunol       Date:  2001-01       Impact factor: 16.687

Review 3.  Control of apoptosis by Rel/NF-kappaB transcription factors.

Authors:  M Barkett; T D Gilmore
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

Review 4.  Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment.

Authors:  R C Stein
Journal:  Endocr Relat Cancer       Date:  2001-09       Impact factor: 5.678

5.  Akt phosphorylates and regulates the orphan nuclear receptor Nur77.

Authors:  Y Pekarsky; C Hallas; A Palamarchuk; A Koval; F Bullrich; Y Hirata; R Bichi; J Letofsky; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

6.  AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival.

Authors:  Ying Li; Donald Dowbenko; Laurence A Lasky
Journal:  J Biol Chem       Date:  2001-12-27       Impact factor: 5.157

7.  Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis.

Authors:  M Los; M Van de Craen; L C Penning; H Schenk; M Westendorp; P A Baeuerle; W Dröge; P H Krammer; W Fiers; K Schulze-Osthoff
Journal:  Nature       Date:  1995-05-04       Impact factor: 49.962

8.  Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo.

Authors:  Z Luo; Y Fujio; Y Kureishi; R D Rudic; G Daumerie; D Fulton; W C Sessa; K Walsh
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 9.  The PI3K-PDK1 connection: more than just a road to PKB.

Authors:  B Vanhaesebroeck; D R Alessi
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

10.  IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase.

Authors:  M Los; H Schenk; K Hexel; P A Baeuerle; W Dröge; K Schulze-Osthoff
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

View more
  20 in total

Review 1.  Mechanisms of Apoptin-induced cell death.

Authors:  Suna Zhou; Mingxin Zhang; Jia Zhang; Hui Shen; Ermek Tangsakar; Jiansheng Wang
Journal:  Med Oncol       Date:  2011-11-22       Impact factor: 3.064

2.  Influence of proline-rich inositol polyphosphate 5-phosphatase, on early development of fertilized mouse eggs, via inhibition of phosphorylation of Akt.

Authors:  X Deng; C Feng; E-H Wang; Y-Q Zhu; C Cui; Z-H Zong; G-S Li; C Liu; J Meng; B-Z Yu
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

3.  The collective nuclear migration of p53 and phosphorylated S473 of Akt during ellipticine-mediated apoptosis in human lung epithelial cancer cells.

Authors:  Jing-Ping Wang; Ya-Chu Yu; Shih-Ping Chen; Huan-Chang Liang; Chia-Wei Lin; Kang Fang
Journal:  Mol Cell Biochem       Date:  2015-05-27       Impact factor: 3.396

4.  S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3.

Authors:  Saeid Ghavami; Mehdi Eshragi; Sudharsana R Ande; Walter J Chazin; Thomas Klonisch; Andrew J Halayko; Karol D McNeill; Mohammad Hashemi; Claus Kerkhoff; Marek Los
Journal:  Cell Res       Date:  2009-11-24       Impact factor: 25.617

Review 5.  Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications.

Authors:  Sabine Hombach-Klonisch; Soumya Panigrahi; Iran Rashedi; Anja Seifert; Esteban Alberti; Paola Pocar; Maciej Kurpisz; Klaus Schulze-Osthoff; Andrzej Mackiewicz; Marek Los
Journal:  J Mol Med (Berl)       Date:  2008-07-16       Impact factor: 4.599

6.  Secretory Transactivating Transcription-apoptin fusion protein induces apoptosis in hepatocellular carcinoma HepG2 cells.

Authors:  Su-Xia Han; Jin-Lu Ma; Yi Lv; Chen Huang; Hai-Hua Liang; Kang-Min Duan
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

7.  S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway.

Authors:  Saeid Ghavami; Iran Rashedi; Brian M Dattilo; Mehdi Eshraghi; Walter J Chazin; Mohammad Hashemi; Sebastian Wesselborg; Claus Kerkhoff; Marek Los
Journal:  J Leukoc Biol       Date:  2008-03-13       Impact factor: 4.962

8.  Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity.

Authors:  Subbareddy Maddika; Soumya Panigrahi; Emilia Wiechec; Sebastian Wesselborg; Ute Fischer; Klaus Schulze-Osthoff; Marek Los
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

Review 9.  Cancer stem cells as targets for cancer therapy: selected cancers as examples.

Authors:  Sabine Hombach-Klonisch; Ted Paranjothy; Emilia Wiechec; Paola Pocar; Tarek Mustafa; Anja Seifert; Christian Zahl; Klaus Luis Gerlach; Katharina Biermann; Klaus Steger; Cuong Hoang-Vu; Klaus Schulze-Osthoff; Marek Los
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291

10.  Interaction with PI3-kinase contributes to the cytotoxic activity of apoptin.

Authors:  S Maddika; E Wiechec; S R Ande; I K Poon; U Fischer; S Wesselborg; D A Jans; K Schulze-Osthoff; M Los
Journal:  Oncogene       Date:  2007-12-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.